UMA
INFI

USA Mutuals Advisors’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

USA Mutuals Advisors’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-214
Closed -$2K – 166
2015
Q2 		$2K Buy
+214
New +$2.75K ﹤0.01% 109

Other funds holding INFI

ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

USA Mutuals Advisors's INFI Position: Q3 2015 in Review

USA Mutuals Advisors sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2015, closing a stake of 214 shares — an estimated $2K sold.

USA Mutuals Advisors first reported a position in INFI in Q2 2015 and held it in 1 quarter. The position peaked at $2K in Q2 2015. 129 funds tracked by Wall St. Rank hold INFI as of Q3 2015.

  • USA Mutuals Advisors reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2015 after selling out during the quarter.
  • USA Mutuals Advisors sold 214 Infinity Pharmaceuticals, Inc. shares in Q3 2015, an estimated $2K.
  • USA Mutuals Advisors first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2015 and held it in 1 quarter.
  • USA Mutuals Advisors's Infinity Pharmaceuticals, Inc. position peaked at $2K in Q2 2015.
  • 129 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2015.

Based on USA Mutuals Advisors's 13F filing for Q3 2015, filed 12 Nov 2015.